Puma Biotechnology Inc
PBYI
Get informed when a big investor buys or sells
+ FollowMarket Cap$488.63M
Close$
$16.00
63% upside
Current Fair Value
63% upsideUndervalued by 63% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $488.63 Million |
|---|---|
| Enterprise Value | $456.95 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.62 |
| Beta | 1.23 |
| Outstanding Shares | 50,939,946 |
Return
| Return on Equity | 19.22% |
|---|---|
| Return on Assets | 13.82% |
| Return on Invested Capital | 22.67% |
Valuation & Multiples
| P/E Ratio | 17.9 |
|---|---|
| PEG | 44.91 |
| Price to Sales | 2.46 |
| Price to Book Ratio | 4.91 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | 14.1 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$53.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$57.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2950▲ 29.50% |
|---|---|
| Total Calls | 81,700▼ 26.46% |
| Total Puts | 24,100▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 76.19%▲ 1.72% |
|---|---|
| Total Invested | $314.72M▲ 30.14% |
| Investors Holding | 166▲ 7.00% |
ESG Score
No data